top of page
Learn More
Neglected tropical diseases
affect more than 1 billion people every year.
The World Health Organisation have identified a group of Neglected Tropical Diseases (NTDs) for elimination but without sensitive and reliable diagnostic tests many who suffer from them will go untreated. As little profit can be made commercial companies do not invest in R&D for new products. Our research-based charity drives the development and manufacture of easy to use Lateral Flow Tests (LFT) for remote tropical villages and rural medical centres.
Diagnosis is the first step.
By coupling disease markers with tried and tested dipstick technology (as found in pregnancy tests), we enable the diagnosis of neglected tropical diseases, such as Chagas Disease, by a non-specialists at the point of care.
"While the focus of biotechnology companies on neglected disease has been lacking for decades, we at TroZonX17 have the expertise and research network to help bridge the gap and develop tests
to connect the world’s most vulnerable to life-saving treatments.”
Barrie Rooney
CEO and Founder
bottom of page